BriaCell Therapeutics Corp.
BCTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001610820
No open-market purchases or sales by BriaCell Therapeutics Corp. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $1.58M in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in BriaCell Therapeutics Corp. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 26
- +5 vs. Q3 2023
- Shares held
- 2.49M
- −220.0K (−8.1%) vs. Q3 2023
- Total value
- $14.6M
- −$2.41M (−14.2%) vs. Q3 2023
- New holders
- 7
- 7 more added
- Sold out
- 2
- 6 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BCTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 19 | $1.58M |
| Q1 2026 | 16 | $1.62M |
| Q4 2025 | 13 | $69.2K |
| Q3 2025 | 13 | $136.5K |
| Q2 2025 | 16 | $181.1K |
| Q1 2025 | 14 | $94.1K |
| Q4 2024 | 26 | $379.1K |
| Q3 2024 | 22 | $538.1K |
| Q2 2024 | 20 | $452.0K |
| Q1 2024 | 20 | $6.38M |
| Q4 2023 | 26 | $14.6M |
| Q3 2023 | 21 | $17.0M |
| Q2 2023 | 21 | $17.9M |
| Q1 2023 | 21 | $19.4M |
| Q4 2022 | 21 | $12.3M |
| Q3 2022 | 22 | $14.3M |
| Q2 2022 | 22 | $17.0M |
| Q1 2022 | 18 | $33.5M |
| Q4 2021 | 20 | $10.9M |
| Q3 2021 | 21 | $4.77M |
| Q2 2021 | 24 | $20.3M |
| Q1 2021 | 10 | $1.45M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding BriaCell Therapeutics Corp.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Lynwood Capital Management Inc. | 1,580,645 | $9.25M | 40.71% | −1,805−0.1% | Reduced |
| Wasatch Advisors Inc | 267,410 | $1.56M | 0.01% | −246,351−48.0% | Reduced |
| Redmond Asset Management, LLC | 133,569 | $781.4K | 0.25% | −4,270−3.1% | Reduced |
| K.J. Harrison & Partners Inc | 80,715 | $476.0K | 0.08% | +14,625+22.1% | Added |
| Morgan Stanley | 64,801 | $379.1K | 0.00% | −30,214−31.8% | Reduced |
| Susquehanna International Group, LLP | 62,322 | $364.6K | 0.00% | +10,255+19.7% | Added |
| Bank of Montreal | 54,116 | $318.6K | 0.00% | +16,487+43.8% | Added |
| Summit Trail Advisors, LLC | 35,000 | $204.8K | 0.01% | 00.0% | Unchanged |
| Onyx Bridge Wealth Group LLC | 30,000 | $175.5K | 0.04% | +30,000 | New |
| Marex Group plc | 30,000 | $175.5K | 0.01% | +30,000 | New |
| Natixis | 22,281 | $130.3K | 0.00% | −73,300−76.7% | Reduced |
| Royal Bank of Canada | 18,600 | $109.0K | 0.00% | +15,000+416.7% | Added |
| Bank of America Corp | 17,799 | $104.1K | 0.00% | +137+0.8% | Added |
| HighTower Advisors, LLC | 15,887 | $93.0K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 14,953 | $87.5K | 0.00% | +14,953 | New |
| TD Waterhouse Canada Inc. | 12,050 | $76.4K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 12,500 | $73.0K | 0.00% | +12,500 | New |
| Atom Investors LP | 10,972 | $64.2K | 0.01% | +10,972 | New |
| Renaissance Technologies LLC | 10,900 | $64.0K | 0.00% | +700+6.9% | Added |
| Concord Wealth Partners | 10,775 | $63.0K | 0.01% | 00.0% | Unchanged |
| National Bank of Canada | 7,500 | $40.0K | 0.00% | +5,000+200.0% | Added |
| Tower Research Capital LLC (TRC) | 528 | $3.09K | 0.00% | 00.0% | Unchanged |
| Advisory Services Network, LLC | 300 | $1.75K | 0.00% | +300 | New |
| UBS Group AG | 15 | $88 | 0.00% | +15 | New |
| Advisor Group Holdings, Inc. | 12 | $70 | 0.00% | −20−62.5% | Reduced |
| Rosenberg Matthew Hamilton | 12 | $70 | 0.00% | 00.0% | Unchanged |
| K2 Principal Fund, L.P. | 0 | $0 | 0.00% | −24,969−100.0% | Sold out |
| Toronto Dominion Bank | 0 | $0 | 0.00% | −33−100.0% | Sold out |